Navigation Links
Harden Healthcare Expands Relationship with Sandata Technologies
Date:6/23/2009

Girling Health Care to utilize Santrax Time and Attendance solution for field employees in Texas

PORT WASHINGTON, N.Y. and AUSTIN, Texas, June 23 /PRNewswire/ -- Sandata Technologies, Inc., a leading nationwide provider of information technology solutions to the home healthcare and social services communities, and Girling Health Care, a Harden Healthcare company, announced an agreement by which Girling will utilize Santrax to manage time and attendance of its field-based employees within its Texas-based operations. Santrax, Sandata's patented time and attendance product, is the nation's number one telephone and web-based field management solution for home healthcare and social services. Through the deployment of Santrax, Girling will benefit from a streamlining of administrative costs as well as improved billing cycles. This agreement represents an expansion of the Sandata-Harden partnership as Sandata currently provides time and attendance solutions to Harden operations in other states including New York and Missouri.

Bert Brodsky, Chairman and CEO of Sandata, said, "We are delighted that Harden has elected to expand its relationship with Sandata to include its Texas operations. Harden is already one of our premier clients and it is truly gratifying to have such a prestigious service company continue to select our home-care solution."

Wayne Douglas, President of Girling Community Care, said, "After an extensive selection process examining alternative solutions, we determined that Sandata provided the best match for our needs. We look forward to expanding the use of Sandata solutions to our Texas operations."

About Sandata Technologies, Inc.

Sandata Technologies provides a complete package of information technology solutions for the home healthcare and social services communities, which includes scheduling, time and attendance, billing, payroll, compliance and
'/>"/>

SOURCE Sandata Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hardened Arteries Threaten Obese, Diabetic Youth
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. MDS to Present at Thomas Weisel Partners Healthcare Conference
8. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
9. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...or Not helps families prepare for and embrace cari...nnati, Ohio (PRWEB) December 2, 2009 -- Charles Pu...ies understand and embrace the challenges of careg...s live long, healthy and prosperous lives, the rea...t, and their needs often become evident during the...
(Date:12/1/2009)...will be given by Estes Audiology to worthy recipie...ustin, TX (PRWEB) December 1, 2009 -- Estes Audiol...ing healthcare provider dedicated to improving the... announced today the beginning of its “Gift ...tes Audiology donates two pairs of hearing aids in...
(Date:12/1/2009)... MD was elected to the Stemedica Cell Technologies...s at the Company’s November 20th Board Meeti... 2009 -- Anthony M. Marlon, MD was elected to the ...ica”) Board of Directors at the Company&rsqu...D, Executive Chairman for Stemedica made the annou...
(Date:12/1/2009)... To date, hospitals have not found ...or the $20 cost of the disposable sensor for your ... Anesthesiologists have not told hospitals how imp...a from routine anesthesia over-medication. ,, A...dication, message from their leaders because their...
(Date:12/1/2009)...re-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Na...he 21st Annual Piper Jaffray Health Care Conferenc...e will be webcast live at www.celltherapeutics.co...lmes 1 at the New York Palace Hotel, and will also..., , Piper Jaffray Health Care...
Breaking Medicine News(10 mins):Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2
...rsity School of Medicine reported that women who s...ften do not report their discomfort or seek medica...en they do report to their medical practitioner th...stimated to affect about one third of the adult wo...
...eived its first tentative approval from the US Foo.../ and market lamivudine tablets that can be used i...(ARVs) to treat patients with HIV infection. ...he other ARVs including the present lamivudine tab...
...yme’s new role in aiding joint inflammations in co...cathepsin G can regulate the ability of the immune...ocess of inflammatory conditions that can lead to ...nflammatory condition of arthritis. Researche...
...dwide suffer from Filarial infection and some// ge...their legs resemble that of an Elephant. The condi...crofti, this is a threadlike worm They go and hous...enitalia like the scrotum, penis or vulva. The...
...cover a new molecular structure that may be// used...sing stem cell technology. The research had l...t controls an important part of retinal cell diffe...chnology to create new retinal cells. Stem ...
...pe 1 or type 2 are at increased risk from having r...and skin infections. Some other problems tha...re kidney damage, nerve damage, eye problems that ...ns dealing with the disease currently know these. ...
Other Medicine News:Health News:Antibiotics help combat dangerous tropical disease 2
(Date:11/30/2009)...COTTSDALE, Ariz., Nov. 30 /PRNewswire-FirstCall/ -...er of radiology solutions to radiology groups and ...ented a redesigned Quality Assurance (QA) program ... radiologists and customers and to deliver superio...g an overview of the new QA program in several pre...
(Date:11/30/2009)... NEW YORK, Nov. 30 Reportlinker.co...vailable in its catalogue: ,, Outsourcing Oppo..., http://www.reportlinker.com/p0165747/Outsourci..., Report Description ,, Medical devices form on...ith an estimated size of $250 billion in 2009 and ...
(Date:11/30/2009)...UREL, N.J., Nov. 30 ... of technology-enabled clinical documentation serv... Radiological Society of North America (RSNA) conf...logy, the product leverages SpeechQ(TM), the compa...ication used by thousands of radiologists. MedQui...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 1Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 3Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 4Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 5Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 6Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 7Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 8Athera Receives Allowance of Two Key Patents 14468 1Athera Receives Allowance of Two Key Patents 14468 2Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 1Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 2Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 3
...e,powers of testosterone, we usually do not consid...at testosterone levels may affect men,s,cognitive ...vard Men,s,Health Watch., All the body,s attribut...ception. Memory is the most fragile mental functio...on is processed less carefully, and,details often ...
... Traditional Approval -, YARDLEY, Pa., Dec. 21 T...pplemental New Drug Application (sNDA) to the U.S....se inhibitor (PI) PREZISTA(TM),(darunavir) tablets...,indication to include human immunodeficiency viru...lication includes 48-week data from two,Phase 3 st...
Other Medicine Technology:Testosterone May Improve Mental Function, From the Harvard Men's Health Watch 2Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 2Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 3Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 4Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 5
Donor Collet, 0.6 mm, Spare part for ATA100
Recipient Stylus, 2.0 mm, Spare part for ATA100
Pulley for Cable, Spare part for ATA100
Knife Raising Block
Medicine Products: